Search results (1157)
« Back to NewsTreating bullying as everyone’s problem reduces incidence in primary schools
8 November 2024
The largest trial of its kind in the UK has shown how a low-cost, structured, anti-bullying programme can improve social dynamics in primary schools and reduce victimisation.
Discovery of key mechanism in Huntington’s Disease could pave the way for early detection and treatment
30 October 2024
Researchers from the University of Oxford have identified a key biochemical mechanism relevant to the development of Huntington’s Disease. This discovery opens up the possibility of studying the disease before its clinical onset and eventually stopping its progression.
Ineos Oxford Institute awards over £2m to innovative projects to tackle antimicrobial resistance
29 October 2024
The Ineos Oxford Institute for antimicrobial research (IOI) has awarded over £2m to six projects across the University of Oxford focused on developing new solutions to tackle antimicrobial resistance (AMR).
Akerman group study describes first new all-optical tool for quantifying inhibitory receptor driving forces
28 October 2024
A new paper from the Akerman group, published in the journal Nature Communications this week, explains the development of a new ‘ORCHID’ (Optical Reporting of CHloride Ion Driving) biosensor to measure the driving force acting on inhibitory receptors in the brain.
New Minichiello research explores the role of cell dysfunction in ataxic symptoms
23 October 2024
A new study from the Minichiello group, published recently in the journal Biology, has shown that dysfunction in BDNF-TrkB signalling, restricted to a specific subset of cerebellar granule cells, is sufficient to generate ataxic symptoms
35 Years of the MRC WIMM- Medical Research Council Weatherall Institute of Molecular Medicine
23 October 2024
In 1989, Sir David Weatherall founded the Institute of Molecular Medicine to bridge the gap between basic science and clinical medicine. To mark 35 years since the MRC WIMM opened its labs, we're looking back on some of our highlights and achievements.
Cellular roadmap reveals new paths to treating inflammatory bowel disease
22 October 2024
In a world first, researchers at the Kennedy Institute, Oxford have mapped the cellular dynamics following treatment with the most commonly used advanced therapy in autoimmune diseases. They have discovered why some patients benefit from this therapy while others do not, potentially paving the way for new therapies.
New Type 1 Diabetes Grand Challenge funding to develop drugs from bugs
22 October 2024
Today the Type 1 Diabetes Grand Challenge, a trailblazing partnership between the Steve Morgan Foundation, Diabetes UK, and Breakthrough T1D (formerly JDRF) has announced funding for a cutting-edge research project led by researchers in the Radcliffe Department of Medicine, which could bring us closer to a cure for type 1 diabetes.
Study Publishes New Insights on Goblet Cell Differentiation in Colorectal Cancer
15 October 2024
The Oncology Department at the University of Oxford is excited to announce the forthcoming publication in the Proceedings of the National Academy of Sciences (PNAS) of the research paper “Goblet Cell Differentiation Subgroups in Colorectal Cancer.” This groundbreaking study sheds light on the role of goblet cell differentiation in colorectal cancer (CRC) and its impact on cancer progression and prognosis.
Typhoid vaccine trial confirms sustained protection for older children
11 October 2024
A single dose of typhoid conjugate vaccine (TCV) offers safe, effective protection against typhoid two years after vaccination in all children, and sustained protection for older children at three to five years post immunisation, according to a report by researchers at the Oxford Vaccine Group and the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b). But it also shows a decline in protection at the later timepoints among children vaccinated at younger ages.
New research network unites Oxford University’s global fight against antimicrobial resistance
9 October 2024
A new University-wide network on antimicrobial resistance aims to generate novel research and collaborations to tackle one of the most urgent global health threats.
Oxford researchers secure funding for world's first ovarian cancer prevention vaccine
7 October 2024
Researchers have been awarded funding from Cancer Research UK to create the world’s first vaccine to prevent ovarian cancer.
US adults in worse health than British counterparts at midlife
3 October 2024
US adults have significantly worse health in midlife compared to their British peers, especially in markers of cardiovascular health, according to a new study involving researchers from Oxford’s Leverhulme Centre for Demographic Science, published in the International Journal of Epidemiology.
New GSK collaboration will develop use of biostatistics and AI in research
30 September 2024
With a base in the University's Nuffield Department of Medicine and Department of Statistics, the collaboration will draw upon biostatistical and artificial intelligence (AI) expertise across Oxford, prioritising the development of innovative new tools and methods that translate to medical and biopharmaceutical research.
New multidisciplinary programme to develop digital pandemic tools
27 September 2024
The Oxford Martin Programme on Digital Pandemic Preparedness will be co-led by researchers affiliated with the Pandemic Sciences Institute.
Access, prevention, and education: three key pillars to tackle antimicrobial resistance effectively
26 September 2024
Timothy Walsh, Director of Biology at the Ineos Oxford Institute for antimicrobial research outlines three priorities that global leaders must consider at the UN High-Level Meeting on AMR held today.
Urgent action needed to understand links between air pollution and mental health
19 September 2024
Leading scientists are calling for urgent global action to better understand the links between air pollution and mental health.
Launch of new podcast series Trusting the Science
19 September 2024
The Oxford Vaccine Group is celebrating 30 years of life-saving vaccine development with the release of a new podcast series of conversations called Trusting the Science. This is the second series of The Oxford Colloquy - a series of discourses hosted by Professor Sir Andrew Pollard who has been Director of the group for over 20 years - and each episode delves into the crucial role that science plays in our understanding of health and immunity.
Researchers develop new tool to better predict AML outcomes in older patients
17 September 2024
In a study published in the Journal of Clinical Oncology, an international research team has used machine learning to improve risk stratification for patients over 60 diagnosed with acute myeloid leukaemia, an aggressive type of blood cancer.
Antibiotic resistance has claimed at least one million lives each year since 1990: GRAM
16 September 2024
Landmark GRAM Project study of global AMR burden over time forecasts a sharp rise in deaths, with 39 million lives lost between now and 2050